(Q71812273)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587999%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

review article

1 reference

title

Drugs for Parkinson's disease reviewed (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587999%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7587999

27 May 2024

publication date

1 July 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587999%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

https://syndication.highwire.org/content/doi/10.1136/dtb.1995.33749

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

Drug and therapeutics bulletin

27 May 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587999%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587999%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587999%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

49-52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7587999%20AND%20SRC:MED&resulttype=core&format=json

The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way

21 October 2019

cites work

5

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way

27 May 2024

6

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Parkinson Study Group

27 May 2024

7

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom

27 May 2024

8

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

When should levodopa be started?

27 May 2024

9

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

Defining small differences in efficacy between anti-parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor

27 May 2024

10

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

Comparative multiple-dose pharmacokinetics of controlled-release levodopa products

27 May 2024

11

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

The use of Sinemet CR in the management of mild to moderate Parkinson's disease

27 May 2024

12

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

Optimization of levodopa therapy

27 May 2024

13

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

Drug treatment of Parkinson's disease

27 May 2024

17

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

Subcutaneous apomorphine in the treatment of Parkinson's disease

27 May 2024

18

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

Speech therapy for patients with Parkinson's disease.

27 May 2024

21

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

Speech therapy for patients with Parkinson's disease.

27 May 2024

22

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

Speech therapy for Parkinson's disease

27 May 2024

23

1 reference

https://api.crossref.org/works/10.1136/DTB.1995.33749

27 May 2024

Identifiers

0 references

1 reference